Julia Saul reports on IIR PharmaMarketing '94 Conference
Ask Jean-Pierre Garnier, chairman designate of SmithKline Beecham Pharmaceuticals "what's changing in pharmaceutical marketing?" and he's likely to answer "everything." In fact he may even go on to tell you that those pharmaceutical companies not making the right move now will fall by the wayside. Current health care reforms are threatening the industry's success on a worldwide scale.
In the UK and USA, health care reform is seen to be politically advantageous, forcing the apparent price of the drugs bill down, and kidding the public into believing it is getting better value for money. There is little risk of retaliation from physicians, and public perception of the pharmaceutical industry is that it is excessively profitable. In the words of Dr Garnier, all this makes the industry "an easy chicken to pluck."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze